Gurugram: In what comes as a sigh of reduction for the docs attending to the sufferers amid the second wave of the pandemic, the primary Covid-19 affected person in India handled with a monoclonal antibodies cocktail was discharged from the Medanta Hospital in Gurugram, Haryana, on Wednesday.
Medanta Hospital chairman Dr Naresh Trehan mentioned that an aged man with a number of comorbidities went residence after getting the jab, including the “monoclonal antibodies cocktail has been extensively in the US and Europe”.
“The experience shows when given in first seven days of (Covid) infection, 70-80 per cent of people who are going to be entering hospitals for treatment will not need hospitalisation,” ANI quoted Dr Trehan as saying.
The Medanta Hospital chairman mentioned they may proceed to watch the affected person, who went residence at this time.
“We are going to follow him. Virus multiplication drops especially in those people who have high virus load and also in those who are at high risk of severe infection,” Dr Trehan mentioned.
“When Casirivimab and Imdevimab are injected into infected patient in early stage it blocks virus from entering cells of patient. It is working against COVID-19 and also effective against B.1.617 variant. This is a new weapon,” he added.
Dr Satya Prakash Yadav, Director, Pediatric Hematology Oncology and Bone Marrow Transplant, Medanta Hospital, too confirmed the same.
“Finally monoclonal antibodies cocktail to treat COVID-19 available in market and today first patient to get it Medanta is an 84-year-old gentleman with COVID-19. Let’s hope it helps cure more patients with COVID-19,” he tweeted.
Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )
